NDC 59651-617 – Rufinamide
Rufinamide 400 mg/1 · Tablet, Film Coated · Oral
Product NDC59651-617
Product details
- Brand name
- Rufinamide
- Generic name
- Rufinamide
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA217230
- Marketed since
- June 16, 2023
- Listing expires
- December 31, 2026
Active ingredients
- Rufinamide 400 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 59651-617-08 | 120 TABLET, FILM COATED in 1 BOTTLE (59651-617-08) | Jun 16, 2023 |
Recalls mentioning this NDC
- D-1087-2023 Aug 30, 2023 · Class II
cGMP deviations: Batch was released prior to approval. - D-1088-2023 Aug 30, 2023 · Class II
cGMP deviations: Batch was released prior to approval.
Other Rufinamide products
- 59651-616 Rufinamide 200 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 31722-598 Rufinamide 200 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 31722-599 Rufinamide 400 mg/1 · Tablet, Film Coated · Camber Pharmaceuticals, Inc.
- 68462-714 Rufinamide 400 mg/1 · Tablet, Film Coated · Glenmark Pharmaceuticals Inc., USA
- 68462-713 Rufinamide 200 mg/1 · Tablet, Film Coated · Glenmark Pharmaceuticals Inc., USA
- 0054-0426 Rufinamide 400 mg/1 · Tablet, Film Coated · Hikma Pharmaceuticals USA Inc.
- 0054-0425 Rufinamide 200 mg/1 · Tablet, Film Coated · Hikma Pharmaceuticals USA Inc.
- 68180-804 Rufinamide 400 mg/1 · Tablet, Film Coated · Lupin Pharmaceuticals, Inc.
- 68180-803 Rufinamide 200 mg/1 · Tablet, Film Coated · Lupin Pharmaceuticals, Inc.
- 60687-824 Rufinamide 40 mg/mL · Suspension · American Health Packaging
- 67877-673 Rufinamide 40 mg/mL · Suspension · Ascend Laboratories, LLC
- 59651-563 Rufinamide 40 mg/mL · Suspension · Aurobindo Pharma Limited